From professional translators, enterprises, web pages and freely available translation repositories.
pergolide
pergolid
Last Update: 2014-12-09
Usage Frequency: 26
Quality:
pergolide (product)
pergolid
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
pergolide [chemical/ingredient]
pergolid
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
cabergoline, lisuride and pergolide (for parkinson’ s disease).
parkinsons sjukdom), kabergolin, lisurid eller pergolid, (mot parkinsons sjukdom).
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
lisuride, pergolide: risk of vasoconstriction and increase in blood pressure.
lisurid, pergolid: risk för vasokonstriktion och ökat blodtryck.
Last Update: 2012-04-11
Usage Frequency: 1
Quality:
drugs shown in animal studies not to interfere with datscan imaging include pergolide.
läkemedel som vid djurstudier inte visats påverka bildkvaliteten med datscan inkluderar pergolid.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
medicinal products shown in animal studies not to interfere with datscan imaging include pergolide.
läkemedel som vid djurstudier inte visats påverka bildkvaliteten med datscan inkluderar pergolid.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bromocriptine, cabergoline, lisuride, pergolide: risk of vasoconstriction and increase in blood pressure.
bromokriptin, cabergolin, lisurid, pergolid: risk för vasokonstriktion och ökat blodtryck.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
the following combinations are not recommended: • bromocriptine • cabergoline • lisuride, pergolide: risk of vasoconstriction and increase in blood pressure.
följande kombinationer rekommenderas inte: • bromokriptin • kabergolin • lisurid, pergolid: risk för vasokonstriktion och ökat blodtryck.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
as {invented name} contains pseudo-ephedrine it is also contraindicated in patients who are receiving monoamine oxidase (mao) inhibitor therapy or during the 2 weeks following the stopping of such treatment, and in patients with: − narrow-angle glaucoma, − urinary retention, − cardiovascular diseases such as ischaemic heart disease, tachyarrhythmia and severe hypertension − hyperthyroidism − a history of haemorhagic stroke or with risk factors which could increase the risk of haemorhagic stroke, due to the alpha-mimetic activity of the vasoconstrictor, in combination with vasoconstrictors such as bromocriptine, pergolide, lisuride, cabergoline, ergotamine, dihydroergotamine or any other decongestant drug used as nasal decongestant, either by oral route or by nasal route (phenylpropanolamine, phenylephrine, ephedrine…).
stroke, på grund av den alfa- mimetiska aktiviteten hos kärlsammandragande medel, i kombination med kärlsammandragande medel såsom bromokripitin, pergolid, lisurid, cabergolin, ergotamin, dihydroergotamin eller något annat avsvällande medel, antingen oralt eller nasalt (fenylpropanolamin, fenylefrin, efedrin …).
Last Update: 2011-10-23
Usage Frequency: 1
Quality: